Welcome to the CASSS Discussion Groups

Discussion Groups are intended to enable the local area community of industry, academic, and regulatory professionals to meet and share ideas and experiences, thereby working together to resolve scientific challenges in the field of biopharmaceutical development and regulation. The CASSS Discussion Groups are your opportunity to meet others who understand what you do, in an informal setting, and exchange new ideas. Discussion Groups currently take place virtually and in-person in North America: DC Area and North Carolina and Europe: The Netherlands.

Upcoming Programs

Host Cell Proteins (HCPs) – Risk-based Control Strategies for Established and Novel Therapeutic Biological Products | April 30, 2024 | 15:00 - 17:00 EDT

This DCDG session will discuss best practices to control HCPs for established recombinant protein products and challenges associated with HCP measurements for emerging cell and gene therapy products. In particular, we will discuss how to apply a risk-based approach and leverage prior knowledge to assure product quality and to meet regulatory expectations.

Registration will close April 29, 2024.

For more information, visit DC Discussion Group

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct

Attend

Host Cell Proteins (HCPs) – Risk-based Control Strategies for Established and Novel Therapeutic Biological Products | April 30, 2024 | 15:00 - 17:00 EDT

Join us in person at the IBBR campus where you can network with DC-area CASSS members. The April Discussion Group will be fully in-person. This DCDG session will discuss best practices to control HCPs for established recombinant protein products and challenges associated with HCP measurements for emerging cell and gene therapy products. In particular, we will discuss how to apply a risk-based approach and leverage prior knowledge to assure product quality and to meet regulatory expectations.

Location:
Institute for Bioscience and Biotechnology Research
9600 Gudelsky Dr.
Rockville, MD, USA 20850

 Register for DC Discussion Group 

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct

Past Event Videos

  • 12 Reasons to Join CASSS Community: All Regulatory Disciplines

  • 12 Reasons to Join CASSS Community: Emerging Professionals

  • 12 Reasons to Join CASSS Community: Importance of Volunteers

  • 12 Reasons to Join CASSS Community: Learn and Collaborate

  • 12 Reasons to Join CASSS Community: Passionate Community

  • 12 Reasons to Join CASSS Community: Reconnecting and Problem-Solving

  • 12 Reasons to Join CASSS Community: Young Professionals

  • CASSS Moments: CASSS Forums Leading Scientific Discussion Over the Years

  • CASSS Moments: Discovering Hot Topics for Regulators

  • CASSS Moments: Game Changing Interactions with Regulators

  • CASSS Moments: Regulatory Differences: Managing Products Globally

  • CASSS Moments: Scientific Discussions Addressing Real-Time Issues

  • Why is CASSS an Important Platform for Global Drug Development?

  • Why is CASSS the Best Place for Global CMC Discussions?